摘要
目的:研究B7-H3在胃癌组织中的表达及其与各临床病理变量之间的相关性。方法:采用免疫组织化学法检测113例胃癌手术标本中B7-H3蛋白的表达,分析其与肿瘤浸润性T淋巴细胞及各临床病理参数间的相关性。结果:B7-H3在胃癌组织中高表达(46.9%,53/113);B7-H3的表达与肿瘤浸润性T淋巴细胞呈负相关,P<0.05。淋巴结阳性组中B7-H3+群的百分比(54.8%,40/73)高于无淋巴结转移组(32.5%,13/40),P<0.05。Ⅰ、Ⅱ期患者标本中B7-H3的阳性表达率要明显低于Ⅲ+Ⅳ期组,P<0.05。结论:B7-H3在胃癌组织中高表达,与肿瘤分期、淋巴结转移正相关,与肿瘤浸润T淋巴细胞呈负相关。B7-H3可能通过抑制间质中T细胞的浸润介导胃癌肿瘤免疫逃逸。
OBJECTIVE:To study the expression of B7-H3 and its relation with cancer clinicopathological variables in gastric carcinoma tissues. METHODS:The expression of B7-H3 in 113 surgically resected specimens of gastric carcinoma was evaluated immunohistochemically. RESULTS: In these tumor specimens, 46.9%(53/113) of specimens was positive for B7-H3, which was observed in the cell membrane and/or cytoplasm. The number of T infiltrating lymphoid cells (TILs) in the tumor tissues was much lower in the B7 H3 positive cases than the negative cases(P〈0.05). And it was found that B7-H3 expression was significantly more common in cases with lymph node metastasis [54.8%(40/73) vs 32.5% (13/40)) and stage Ⅲ+Ⅳ(P〈0.05). CONCLUSION:B7-H3 is expressed in the tissues of gastric carcinoma, and B7 H3 expression is negatively correlated with the number of TILs,which may represent one of the immune escape mechanisms for gastric carcinoma.
出处
《中华肿瘤防治杂志》
CAS
2011年第12期946-948,共3页
Chinese Journal of Cancer Prevention and Treatment
基金
山东省优秀中青年科学家奖励基金(2006BS03015)